Corcept Therapeutics CORT Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's change in inventories?
- Corcept Therapeutics (CORT) reported change in inventories of $3.27M in Q1 2026.
- How has Corcept Therapeutics's change in inventories changed year-over-year?
- Corcept Therapeutics's change in inventories increased by 640.8% year-over-year, from -$605K to $3.27M.
- What is the long-term trend for Corcept Therapeutics's change in inventories?
- Over 2 years (2021 to 2025), Corcept Therapeutics's change in inventories has grown at a 52.1% compound annual growth rate (CAGR), from -$3.44M to $7.96M.
- What does change in inventories mean?
- The change in the value of products and materials held in stock.
- How do you interpret change in inventories?
- A large increase may signal overproduction or slowing sales, while a decrease may indicate strong demand or supply chain constraints.
- How does change in inventories compare across companies?
- Crucial for pharmaceutical companies managing drug supply chains and shelf-life expiration risks.